Overview of telmisartan for blood pressure reduction among angiotensin II receptor blockers: A meta-analysis of head-to-head randomized trials

International Journal of Cardiology

Volumn 167, Issue 6, 2013, Pages 3051-3056

  Takagi, Hisato ^a   Mizuno, Yusuke ^a   Goto, Shin Nosuke ^a   Umemoto, Takuya ^a  

^a SHIZUOKA MEDICAL CENTER   (Japan)

Author keywords

Angiotensin II receptor blocker; Meta analysis; Randomized trial; Telmisartan

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; AZILSARTAN; CANDESARTAN; EPROSARTAN; HYDROCHLOROTHIAZIDE; IRBESARTAN; LOSARTAN; OLMESARTAN; ROSIGLITAZONE; ROSUVASTATIN; TELMISARTAN; VALSARTAN;

ANTIHYPERTENSIVE ACTIVITY; COCHRANE LIBRARY; DIASTOLIC BLOOD PRESSURE; EMBASE; HUMAN; INFORMATION RETRIEVAL; LETTER; MEDLINE; META ANALYSIS; MONOTHERAPY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTOLIC BLOOD PRESSURE;

ANGIOTENSIN II RECEPTOR BLOCKER; META-ANALYSIS; RANDOMIZED TRIAL; TELMISARTAN;

ANGIOTENSIN RECEPTOR ANTAGONISTS; BENZIMIDAZOLES; BENZOATES; BLOOD PRESSURE; HUMANS; HYPERTENSION; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84883750449     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.11.086     Document Type: Article

References (56)

1. G.L. Xi, J.W. Cheng, and G.C. Lu Meta-analysis of randomized controlled trials comparing telmisartan with losartan in the treatment of patients with hypertension Am J Hypertens 21 2008 546 552
2. Z. Zheng, S. Lin, and H. Shi A systematic review and meta-analysis of telmisartan versus valsartan in the management of essential hypertension J Clin Hypertens (Greenwich) 12 2010 414 421
3. C.B. Begg, and M. Mazumdar Operating characteristics of a rank correlation test for publication bias Biometrics 50 1994 1088 1101
4. M. Egger, G. Davey Smith, M. Schneider, and C. Minder Bias in meta-analysis detected by a simple, graphical test BMJ 315 1997 629 634
5. S. Duval, and R. Tweedie Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis Biometrics 56 2000 455 463
6. T. Arai, and H. Ohashi Angiotensin receptor blockers and microalbuminuria in hypertensive patients with early (microalbuminuric) stage diabetic nephropathy Mol Med Rep 1 2008 391 393
7. M. Clodi, M. Resl, and D. Stelzeneder Interactions of glucose metabolism and chronic heart failure Exp Clin Endocrinol Diabetes 117 2009 99 106
8. B. Gremmler, K. Kisters, M. Kunert, H. Schleiting, and L.J. Ulbricht Effects of different AT1-receptor antagonists in the therapy of severe heart failure pretreated with ACE inhibitors Acta Cardiol 62 2007 321 328
9. T. Hamada, E. Mizuta, and T. Kondo Effects of a low-dose antihypertensive diuretic in combination with losartan, telmisartan, or candesartan on serum urate levels in hypertensive patients Arzneimittelforschung 60 2010 71 75
10. T. Kishi, Y. Hirooka, S. Konno, and K. Sunagawa Angiotensin II receptor blockers improve endothelial dysfunction associated with sympathetic hyperactivity in metabolic syndrome J Hypertens 30 2012 1646 1655
11. S. Makita, A. Abiko, Y. Naganuma, Y. Moriai, and M. Nakamura Effects of telmisartan on adiponectin levels and body weight in hypertensive patients with glucose intolerance Metabolism 57 2008 1473 1478
12. T. Nakamura, N. Fujiwara, E. Sato, Y. Ueda, T. Sugaya, and H. Koide Renoprotective effects of various angiotensin II receptor blockers in patients with early-stage diabetic nephropathy Kidney Blood Press Res 33 2010 213 220
13. N. Ozaki, Y. Nomura, H. Sobajima, K. Kondo, and Y. Oiso Comparison of the effects of three angiotensin II receptor type 1 blockers on metabolic parameters in hypertensive patients with type 2 diabetes mellitus Eur J Intern Med 21 2010 236 239
14. M. Watanabe, K. Inukai, and T. Sumita Effects of telmisartan on insulin resistance in Japanese type 2 diabetic patients Intern Med 49 2010 1843 1847
15. S. Yamada, N. Ano, and K. Toda Telmisartan but not candesartan affects adiponectin expression in vivo and in vitro Hypertens Res 31 2008 601 606
16. G. Derosa, P.D. Ragonesi, A. Mugellini, L. Ciccarelli, and R. Fogari Effects of telmisartan compared with eprosartan on blood pressure control, glucose metabolism and lipid profile in hypertensive, type 2 diabetic patients: a randomized, double-blind, placebo-controlled 12-month study Hypertens Res 27 2004 457 464
17. R. Fogari, A. Zoppi, and I. Ferrari Comparative effects of telmisartan and eprosartan on insulin sensitivity in the treatment of overweight hypertensive patients Horm Metab Res 41 2009 893 898
18. G. Derosa, A.F. Cicero, and A. D'Angelo Telmisartan and irbesartan therapy in type 2 diabetic patients treated with rosiglitazone: effects on insulin-resistance, leptin and tumor necrosis factor-alpha Hypertens Res 29 2006 849 856
19. R. Negro, G. Formoso, and H. Hassan The effects of irbesartan and telmisartan on metabolic parameters and blood pressure in obese, insulin resistant, hypertensive patients J Endocrinol Invest 29 2006 957 961
20. C.V. Rizos, H.J. Milionis, and M.S. Kostapanos Effects of rosuvastatin combined with olmesartan, irbesartan, or telmisartan on indices of glucose metabolism in Greek adults with impaired fasting glucose, hypertension, and mixed hyperlipidemia: a 24-week, randomized, open-label, prospective study Clin Ther 32 2010 492 505
21. G. Bakris, E. Burgess, M. Weir, and AMADEO Study Investigators Telmisartan is more effective than losartan in reducing proteinuria in patients with diabetic nephropathy Kidney Int 74 2008 364 369
22. O. Bahadir, M. Uzunlulu, A. Oguz, and M.A. Bahadir Effects of telmisartan and losartan on insulin resistance in hypertensive patients with metabolic syndrome Hypertens Res 30 2007 49 53
23. P.Y. Ding, K.M. Chu, H.T. Chiang, and K.H. Shu A double-blind ambulatory blood pressure monitoring study of the efficacy and tolerability of once-daily telmisartan 40 mg in comparison with losartan 50 mg in the treatment of mild-to-moderate hypertension in Taiwanese patients Int J Clin Pract Suppl 145 2004 16 22
24. Z.P. Hu, B.N. Wang, H.Y. Qian, Q. Zhou, W. Wei, and Y. Wang Fixed-dose telmisartan/hydrochlorothiazide in comparison with losartan/hydrochlorothiazide in decreasing serum hepatocyte growth factor and improving endothelial dysfunction in hypertensive patients Int Heart J 51 2010 252 258
25. G.Z. Huang, Y.H. Tang, and B.Y. Wang Effects of telmisartan on insulin resistance and visceral fat distribution in Chinese hypertensive patients with obesity Saudi Med J 32 2011 1017 1021
26. Y. Lacourcière, B. Gil-Extremera, O. Mueller, M. Byrne, and L. Williams Efficacy and tolerability of fixed-dose combinations of telmisartan plus HCTZ compared with losartan plus HCTZ in patients with essential hypertension Int J Clin Pract 57 2003 273 279
27. Y.T. Lee, C.M. Lee, and C.S. Lin A double-blind comparison of the efficacy and tolerability of telmisartan 40-80 mg vs. losartan 50-100 mg in Taiwanese hypertensive patients Int J Clin Pract Suppl 145 2004 40 45
28. J. Mallion, J. Siche, and Y. Lacourcière ABPM comparison of the antihypertensive profiles of the selective angiotensin II receptor antagonists telmisartan and losartan in patients with mild-to-moderate hypertension J Hum Hypertens 13 1999 657 664
29. B. Martina, T. Dieterle, J.P. Sigle, C. Surber, and E. Battegay Effects of telmisartan and losartan on left ventricular mass in mild-to-moderate hypertension. A randomized, double-blind trial Cardiology 99 2003 169 170
30. S. Masuda, K. Tamura, and H. Wakui Effects of angiotensin II type 1 receptor blocker on ambulatory blood pressure variability in hypertensive patients with overt diabetic nephropathy Hypertens Res 32 2009 950 955
31. J. Minami, S. Furukata, T. Ishimitsu, and H. Matsuoka Comparison of therapies between fixed-dose telmisartan/hydrochlorothiazide and losartan/hydrochlorothiazide in patients with mild to moderate hypertension Int Heart J 50 2009 85 93
32. J.M. Neutel, T.W. Littlejohn, S.G. Chrysant, A. Singh, and Telmisartan Study Group Telmisartan/hydrochlorothiazide in comparison with losartan/hydrochlorothiazide in managing patients with mild-to-moderate hypertension Hypertens Res 28 2005 555 563
33. S. Perl, I. Schmölzer, and H. Sourij Telmisartan improves vascular function independently of metabolic and antihypertensive effects in hypertensive subjects with impaired glucose tolerance Int J Cardiol 139 2010 289 296
34. S.S. Samra, N. Dongre, C. Ballary, and A. Desai Comparison of the efficacy, safety and tolerability of telmisartan with losartan in Indian patients with mild to moderate hypertension: a pilot study J Indian Med Assoc 101 2003 327 328
35. D.H. Smith, M.J. Cramer, J.M. Neutel, R. Hettiarachchi, and S. Koval Comparison of telmisartan versus losartan: meta-analysis of titration-to- response studies Blood Press Monit 8 2003 111 117
36. H. Hasegawa, H. Takano, and H. Narumi Effects of telmisartan and losartan on cardiovascular protection in Japanese hypertensive patients Hypertens Res 34 2011 1179 1184
37. C. Vitale, G. Mercuro, and C. Castiglioni Metabolic effect of telmisartan and losartan in hypertensive patients with metabolic syndrome Cardiovasc Diabetol 4 2005 6
38. K. Yamada, T. Hirayama, and Y. Hasegawa Antiplatelet effect of losartan and telmisartan in patients with ischemic stroke J Stroke Cerebrovasc Dis 16 2007 225 231
39. J.R. Zhu, J. Bai, and N.S. Cai Efficacy and safety of telmisartan vs. losartan in control of mild-to-moderate hypertension: a multicentre, randomised, double-blind study Int J Clin Pract Suppl 145 2004 46 49
40. D.A. de Luis, R. Conde, and M. González-Sagrado Effects of telmisartan vs olmesartan on metabolic parameters, insulin resistance and adipocytokines in hypertensive obese patients Nutr Hosp 25 2010 275 279
41. K. Murakami, J. Wada, and D. Ogawa The effects of telmisartan treatment on the abdominal fat depot in patients with metabolic syndrome and essential hypertension: Abdominal fat Depot Intervention Program of Okayama (ADIPO) Diab Vasc Dis Res 10 1 2013 93 96
42. C. Calvo, R.C. Hermida, D.E. Ayala, and L.M. Ruilope Effects of telmisartan 80 mg and valsartan 160 mg on ambulatory blood pressure in patients with essential hypertension J Hypertens 22 2004 837 846
43. E.F. Georgescu, R. Ionescu, M. Niculescu, L. Mogoanta, and L. Vancica Angiotensin-receptor blockers as therapy for mild-to-moderate hypertension-associated non-alcoholic steatohepatitis World J Gastroenterol 15 2009 942 954
44. S.J. Hong, W.J. Shim, and J.I. Choi Comparison of effects of telmisartan and valsartan on late lumen loss and inflammatory markers after sirolimus-eluting stent implantation in hypertensive patients Am J Cardiol 100 2007 1625 1629
45. S.J. Hong, S.C. Choi, C.M. Ahn, J.H. Park, J.S. Kim, and D.S. Lim Telmisartan reduces neointima volume and pulse wave velocity 8 months after zotarolimus-eluting stent implantation in hypertensive type 2 diabetic patients Heart 97 2011 1425 1432
46. Y. Ichikawa Comparative effects of telmisartan and valsartan on insulin resistance in hypertensive patients with metabolic syndrome Intern Med 46 2007 1331 1336
47. Y. Lacourcière, J.M. Krzesinski, W.B. White, G. Davidai, and H. Schumacher Sustained antihypertensive activity of telmisartan compared with valsartan Blood Press Monit 9 2004 203 210
48. S.Y. Lim, S.W. Kim, and E.J. Kim Telmisartan versus valsartan in patients with hypertension: effects on cardiovascular, metabolic, and inflammatory parameters Korean Circ J 41 2011 583 589
49. T. Littlejohn, W. Mroczek, T. Marbury, C.P. VanderMaelen, and R.F. Dubiel A prospective, randomized, open-label trial comparing telmisartan 80 mg with valsartan 80 mg in patients with mild to moderate hypertension using ambulatory blood pressure monitoring Can J Cardiol 16 2000 1123 1132
50. A.M. Sharma, J. Davidson, S. Koval, and Y. Lacourcière Telmisartan/hydrochlorothiazide versus valsartan/hydrochlorothiazide in obese hypertensive patients with type 2 diabetes: the SMOOTH study Cardiovasc Diabetol 6 2007 28
51. H. Tomiyama, J. Yamada, Y. Koji, K. Shiina, M. Yoshida, and A. Yamashina Effect of telmisartan on forearm postischemic hyperemia and serum asymmetric dimethylarginine levels Am J Hypertens 20 2007 1305 1311
52. J. Galle, E. Schwedhelm, S. Pinnetti, R.H. Böger, C. Wanner, and VIVALDI Investigators Antiproteinuric effects of angiotensin receptor blockers: telmisartan versus valsartan in hypertensive patients with type 2 diabetes mellitus and overt nephropathy Nephrol Dial Transplant 23 2008 3174 3183
53. W.B. White, H.A. Punzi, D. Murwin, S.E. Koval, G. Davidai, and J.M. Neutel Effects of the angiotensin II receptor blockers telmisartan vs valsartan in combination with hydrochlorothiazide 25 mg once daily for the treatment of hypertension J Clin Hypertens (Greenwich) 8 2006 626 633
54. W.B. White, D. Murwin, S.G. Chrysant, S.E. Koval, G. Davidai, and R. Guthrie Effects of the angiotensin II receptor blockers telmisartan versus valsartan in combination with hydrochlorothiazide: a large, confirmatory trial Blood Press Monit 13 2008 21 27
55. Y. Yano, S. Hoshide, and J. Ishikawa The differential effects of angiotensin II type 1 receptor blockers on microalbuminuria in relation to low-grade inflammation in metabolic hypertensive patients Am J Hypertens 20 2007 565 572
56. J.P. Baguet, B. Legallicier, P. Auquier, and S. Robitail Updated meta-analytical approach to the efficacy of antihypertensive drugs in reducing blood pressure Clin Drug Investig 27 2007 735 753